tetano
Editor, Senior Moderator
J Affect Disord
. 2020 Jul 2;275:145-148.
doi: 10.1016/j.jad.2020.06.033. Online ahead of print.
Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19
Yu-Fen Ma[SUP] 1 [/SUP], Wen Li[SUP] 2 [/SUP], Hai-Bao Deng[SUP] 3 [/SUP], Lei Wang[SUP] 4 [/SUP], Ying Wang[SUP] 5 [/SUP], Pei-Hong Wang[SUP] 6 [/SUP], Hai-Xin Bo[SUP] 7 [/SUP], Jing Cao[SUP] 7 [/SUP], Yu Wang[SUP] 8 [/SUP], Li-Yun Zhu[SUP] 8 [/SUP], Yuan Yang[SUP] 9 [/SUP], Teris Cheung[SUP] 10 [/SUP], Chee H Ng[SUP] 11 [/SUP], Xinjuan Wu[SUP] 12 [/SUP], Yu-Tao Xiang[SUP] 13 [/SUP]
Affiliations
Abstract
Introduction: High risk of mental health problems is associated with Coronavirus Disease 2019 (COVID-19). This study explored the prevalence of depressive symptoms (depression hereafter) and its relationship with quality of life (QOL) in clinically stable patients with COVID-19.
Methods: This was an online survey conducted in COVID-19 patients across five designated isolation hospitals for COVID-19 in Hubei province, China. Depression and QOL were assessed with standardized instruments.
Results: A total of 770 participants were included. The prevalence of depression was 43.1% (95%CI: 39.6%-46.6%). Binary logistic regression analysis found that having a family member infected with COVID-19 (OR=1.51, P = 0.01), suffering from severe COVID-19 infection (OR=1.67, P = 0.03), male gender (OR=0.53, P<0.01), and frequent social media use to obtain COVID-19 related information (OR=0.65, P<0.01) were independently associated with depression. Patients with depression had lower QOL than those without.
Conclusion: Depression is highly prevalent in clinically stable patients with COVID-19. Regular screening and appropriate treatment of depression are urgently warranted for this population.
Keywords: COVID-19; Depression; Quality of life; Stable.
. 2020 Jul 2;275:145-148.
doi: 10.1016/j.jad.2020.06.033. Online ahead of print.
Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19
Yu-Fen Ma[SUP] 1 [/SUP], Wen Li[SUP] 2 [/SUP], Hai-Bao Deng[SUP] 3 [/SUP], Lei Wang[SUP] 4 [/SUP], Ying Wang[SUP] 5 [/SUP], Pei-Hong Wang[SUP] 6 [/SUP], Hai-Xin Bo[SUP] 7 [/SUP], Jing Cao[SUP] 7 [/SUP], Yu Wang[SUP] 8 [/SUP], Li-Yun Zhu[SUP] 8 [/SUP], Yuan Yang[SUP] 9 [/SUP], Teris Cheung[SUP] 10 [/SUP], Chee H Ng[SUP] 11 [/SUP], Xinjuan Wu[SUP] 12 [/SUP], Yu-Tao Xiang[SUP] 13 [/SUP]
Affiliations
- PMID: 32658818
- DOI: 10.1016/j.jad.2020.06.033
Abstract
Introduction: High risk of mental health problems is associated with Coronavirus Disease 2019 (COVID-19). This study explored the prevalence of depressive symptoms (depression hereafter) and its relationship with quality of life (QOL) in clinically stable patients with COVID-19.
Methods: This was an online survey conducted in COVID-19 patients across five designated isolation hospitals for COVID-19 in Hubei province, China. Depression and QOL were assessed with standardized instruments.
Results: A total of 770 participants were included. The prevalence of depression was 43.1% (95%CI: 39.6%-46.6%). Binary logistic regression analysis found that having a family member infected with COVID-19 (OR=1.51, P = 0.01), suffering from severe COVID-19 infection (OR=1.67, P = 0.03), male gender (OR=0.53, P<0.01), and frequent social media use to obtain COVID-19 related information (OR=0.65, P<0.01) were independently associated with depression. Patients with depression had lower QOL than those without.
Conclusion: Depression is highly prevalent in clinically stable patients with COVID-19. Regular screening and appropriate treatment of depression are urgently warranted for this population.
Keywords: COVID-19; Depression; Quality of life; Stable.